Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.
about
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spreadProactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosisTreatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer.Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives.Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).Is prevention of peritoneal dissemination the next step in the treatment of T4 colon cancer?
P2860
Q34477640-7B8280D2-09BC-4766-9BCB-7839204270EDQ36282838-14B4C55B-04FC-43B3-A2C6-906383489A6FQ36758901-9AC53C8D-0E1E-4CDE-9789-619FA835D283Q36903223-371851C1-38E9-4AAA-A324-103D2C571FFCQ37012644-C46523AF-57C2-4022-872F-4095B9502A87Q39406537-DD8A90C2-5083-4B70-8BD1-D5CE36163889Q39442876-E2601406-C84A-432C-819A-27974DA602FAQ40296834-6C7DC894-F68E-41CC-BBC5-6B254AB62548Q41612691-00A6B949-5A6F-4517-B869-D9DDC057081AQ47716324-AE4BFB97-1153-44F1-BA92-8944C521F8F2Q47795778-FEF39B20-500A-42AD-AFB7-7AF545D60FFCQ49291015-944BAE42-DA17-446C-9284-521654040AC0Q53093164-8140398B-D520-44C1-B004-758BDC1ACE86Q53187645-FBFCFCEB-4E8A-400C-9EE4-190A17C4C7B1
P2860
Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@ast
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@en
type
label
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@ast
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@en
prefLabel
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@ast
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@en
P2093
P2860
P921
P356
P1476
Intraperitoneal chemotherapy a ...... r origin: a systematic review.
@en
P2093
C J A Punt
D A M Sloothaak
J D W van der Bilt
W A Bemelman
P2860
P2888
P304
P356
10.1038/BJC.2014.369
P407
P50
P5008
P577
2014-07-15T00:00:00Z
2014-09-09T00:00:00Z
P5875
P6179
1017114070